David Chiappetta

Aug 2, 2024 | jdsupra.com | Shylah Alfonso |David Chiappetta |Henry Hauser

IntroductionA recent ruling condemning price discrimination for a popular eye drop brand is yet another reminder that companies cannot afford to ignore antitrust risk under the Robinson-Patman Act (RPA), a longstanding law that has made a comeback in recent years. The RPA prohibits charging certain customers more than others without proper justifications. In L.A. International Corporation v.